MK-3475-G21
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Replimune Inc.
Bristol-Myers Squibb
Immatics US, Inc.
Essen Biotech
Essen Biotech
Teva Branded Pharmaceutical Products R&D, Inc.
M.D. Anderson Cancer Center
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
GV20 Therapeutics
Anaveon AG
Palleon Pharmaceuticals, Inc.
Novartis
NuCana plc
Marengo Therapeutics, Inc.
BioAtla, Inc.
Krystal Biotech, Inc.
Xynomic Pharmaceuticals, Inc.
OncoResponse, Inc.
Aminex Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.
Salubris Biotherapeutics Inc
ENB Therapeutics, Inc
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Apexigen America, Inc.
OncoResponse, Inc.
Kineta Inc.
Revolution Medicines, Inc.
4D pharma plc
Bristol-Myers Squibb
Ludwig Institute for Cancer Research
Akeso
Genocea Biosciences, Inc.
Effector Therapeutics
Celgene
Icahn School of Medicine at Mount Sinai
Altor BioScience
BBB-Therapeutics B.V.
National Institutes of Health Clinical Center (CC)
Instituto de Investigação em Imunologia
Adherex Technologies, Inc.
University Hospital, Basel, Switzerland